Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Matter

Showing results (141-150 of 324) with videos related to

Pageof 33
Sort By:
The Journal of Invasive Cardiology|March 2, 2018
Short-Term Outcome After Left Main Interventions in Patients Presenting With Acute Coronary SyndromeSlayman Obeid, Nooraldaem Yousif, Andreas Schelldorfer, et al.
Stroke|June 6, 2013
Multimodal imaging in rats reveals impaired neurovascular coupling in sustained hypertensionNovella Calcinaghi, Matthias T Wyss, Renaud Jolivet, et al.
BMJ Open|September 22, 2016
Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisonsReto Auer, Baris Gencer, Rodrigo Tango, et al.
European Heart Journal Open|June 26, 2026
Weight change and long-term cardiovascular outcomes in overweight and obese patients after acute coronary syndromesLouise Artels, Cédric Follonier, Stéphanie Baggio, et al.
Atherosclerosis|June 15, 2026
A quantitative method to estimate free interleukin-6 among patients treated with the interleukin-6 ligand inhibitor ziltivekimab: comparison to C-reactive protein with implications for the ZEUS, HERMES, and ARTEMIS cardiovascular outcomes trialsPatrick Nolain, Magnus Fugger, Bibi Toft Hellinghus, et al.
Frontiers in Cardiovascular Medicine|October 30, 2023
Effects of SARS-COV-2 infection on outcomes in patients hospitalized for acute cardiac conditions. A prospective, multicenter cohort study (Swiss Cardiovascular SARS-CoV-2 Consortium)Konstantinos C Koskinas, Raphael Twerenbold, David Carballo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 23, 2020
Comparison of P2Y12 receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registriesLeonardo De Luca, Uwe Zeymer, Marc J Claeys, et al.
Plos One|May 6, 2011
Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrolAngana G Rajapakse, Gautham Yepuri, João M Carvas, et al.
Journal of Lipid Research|March 13, 2013
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formationFilippo Molica, Fabienne Burger, Aurélien Thomas, et al.
Clinical Cardiology|November 14, 2018
Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trialKonstantinos C Koskinas, Stephan Windecker, Aliki Buhayer, et al.
Pageof 33

Showing results (141-150 of 324) with videos related to

Sort By:
Pageof 33
The Journal of Invasive Cardiology|March 2, 2018
Short-Term Outcome After Left Main Interventions in Patients Presenting With Acute Coronary SyndromeSlayman Obeid, Nooraldaem Yousif, Andreas Schelldorfer, et al.
Stroke|June 6, 2013
Multimodal imaging in rats reveals impaired neurovascular coupling in sustained hypertensionNovella Calcinaghi, Matthias T Wyss, Renaud Jolivet, et al.
BMJ Open|September 22, 2016
Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisonsReto Auer, Baris Gencer, Rodrigo Tango, et al.
European Heart Journal Open|June 26, 2026
Weight change and long-term cardiovascular outcomes in overweight and obese patients after acute coronary syndromesLouise Artels, Cédric Follonier, Stéphanie Baggio, et al.
Atherosclerosis|June 15, 2026
A quantitative method to estimate free interleukin-6 among patients treated with the interleukin-6 ligand inhibitor ziltivekimab: comparison to C-reactive protein with implications for the ZEUS, HERMES, and ARTEMIS cardiovascular outcomes trialsPatrick Nolain, Magnus Fugger, Bibi Toft Hellinghus, et al.
Frontiers in Cardiovascular Medicine|October 30, 2023
Effects of SARS-COV-2 infection on outcomes in patients hospitalized for acute cardiac conditions. A prospective, multicenter cohort study (Swiss Cardiovascular SARS-CoV-2 Consortium)Konstantinos C Koskinas, Raphael Twerenbold, David Carballo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 23, 2020
Comparison of P2Y12 receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registriesLeonardo De Luca, Uwe Zeymer, Marc J Claeys, et al.
Plos One|May 6, 2011
Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrolAngana G Rajapakse, Gautham Yepuri, João M Carvas, et al.
Journal of Lipid Research|March 13, 2013
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formationFilippo Molica, Fabienne Burger, Aurélien Thomas, et al.
Clinical Cardiology|November 14, 2018
Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trialKonstantinos C Koskinas, Stephan Windecker, Aliki Buhayer, et al.
Pageof 33